Overview

Treatment of Actinic Keratoses of the Face With Imiquimod 3.75% Cream Followed by Photodynamic Therapy

Status:
Terminated
Trial end date:
2011-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to explore the effect of treating actinic keratoses of the face with imiquimod 3.75% cream followed by photodynamic therapy in comparison to treatment with imiquimod alone
Phase:
Phase 4
Details
Lead Sponsor:
Tennessee Clinical Research Center
Collaborator:
Graceway Pharmaceuticals, LLC
Treatments:
Aminolevulinic Acid
Imiquimod